LCGC North America
What is required to optimize a gradient elution HPLC method?
What is involved in developing and optimizing a gradient elution reversed-phase high performance liquid chromatography (HPLC) method? Several factors need to be considered.
Blank Gradient
First, run a blank gradient to ensure there are no problems with baseline drift. Drifting baselines are an insidious problem in gradient elution and are caused by the change in eluent composition. Changes in UV absorbance and refractive index properties are detected, which results in a rising or falling baseline. If possible, change the wavelength that is being monitored (especially at low wavelengths) or use a solvent that does not absorb at the wavelength being monitored. If a diode-array detector is being used, a reference wavelength can be set that compensates for changes in the absorbance and refractive index of the background.
Scouting Gradient
Run a scouting gradient of 5–100% B over 20 min using a mobile-phase A of 10 mM ammonium formate, pH 2.8; a mobile-phase B of acetonitrile; a 150 mm x 4.6 mm, 5-µm C18 column; and a flow rate of 2 mL/min. The use of volatile ammonium formate as a buffer provides the added advantage of making the method compatible with mass spectrometry detection (or other detection modes that require volatile buffers). The chromatographic results allow gradient parameters to be optimized (1). Start by optimizing the initial and final %B based on the retention times of the first and last eluted peaks (equations 1–3) (1).
In equations 1–3, %Binitial = initial %B used in scouting gradient, %Bfinal = final %B used in scouting gradient, tg = gradient time, ti = elution time initial peak (min), tf = elution time final peak (min), VD = dwell volume (mL), and F = flow rate (mL/min).
Gradient Steepness
Optimize gradient steepness using the conditions found from the scouting gradient (equation 4):
In equation 4, k* = gradient retention factor (use 5 as starting point), S = shape selectivity factor (for small molecules use 5 or calculate, S = 0.25MW0.25), and Δφ = change in %B expressed as a decimal, and VM = column interstitial volume (mL). Gradient slope can alter resolution and selectivity; as the slope decreases, resolution increases due to a change in k*.
Reequilibration Time
The next step is to optimize reequilibration time (equation 5) (2):
It is an important step, and if it is not properly considered it can lead to retention time and quantitative variability.
Fine-Tune Parameters
The gradient time can be varied to assess the effect on the analysis (vary by twofold or more); changes in resolution of critical pairs should be noted. When varying the gradient time, the initial and final %B values may need to be adjusted. If further optimization is required, vary the solvent type (neutral samples), followed by column chemistry. For ionizable analytes, variations in pH or temperature should be investigated before changing column chemistry. Gradient steepness should be reoptimized following any changes in solvent or column.
Analysis Time
After conditions have been optimized using the steps above, the analysis time can be reduced by varying the flow rate, column length, or particle size. If the flow rate has been changed, a final adjustment of the reequilibration time can be made to optimize overall analysis time. When adjusting column conditions, selectivity, but not necessarily resolution, can be kept constant (that is, the same elution order) by maintaining k* using the gradient steepness (GS). Change the flow rate: alter tG to keep GS constant; change the column length: alter tG or F to keep GS constant; change the column internal diameter: alter tG or F to keep GS constant (equation 6).
Dwell Volume
Dwell volume differences between systems may cause changes in selectivity and resolution when transferring methods (3). The solution is to insert an isocratic hold or use injection delay. System wash-out volume will also affect method transfer. This is the time taken for the instrument to wash-out the strong solvent channel and can be as much or more than the dwell volume. This can affect reequilibration, which cannot occur until the initial eluent conditions are reached.
References
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
2024 EAS Awardees Showcase Innovative Research in Analytical Science
November 20th 2024Scientists from the Massachusetts Institute of Technology, the University of Washington, and other leading institutions took the stage at the Eastern Analytical Symposium to accept awards and share insights into their research.